Browse by Phase
Phase 2 Clinical Trials
Phase 2 trials study whether a drug works in people with a specific disease or condition. These studies enroll 100–300 participants and also continue to evaluate safety.
Total Trials
1,071
Recruiting Now
1,071
Top Conditions in Phase 2
NCT06824064 Phase 2
Recruiting
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Col...
Condition
Metastatic Colorectal Cancer
Enrollment
150 pts
Location
United States, Vietnam
Sponsor
Riboscience, LLC.
NCT04930653 Phase 2
Recruiting
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermi...
Condition
Folliculotropic Mycosis Fungoides
Enrollment
34 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT05334277 Phase 2
Recruiting
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC ...
Condition
Non-small Cell Lung Cancer
Enrollment
280 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05873712 Phase 2
Recruiting
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrom...
Condition
Recurrent Transformed Chronic Lymphocytic Leukemia
Enrollment
24 pts
Location
United States
Sponsor
Aseel Alsouqi
NCT06687681 Phase 2
Recruiting
Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Condition
Glioma Glioblastoma Multiforme
Enrollment
40 pts
Location
Iran
Sponsor
Marzieh Ebrahimi
NCT06686030 Phase 2
Recruiting
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensi...
Condition
Platinum-sensitive Ovarian Cancer
Enrollment
150 pts
Location
China
Sponsor
Akeso
NCT03986034 Phase 2
Recruiting
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chr...
Condition
Chronic Lymphocytic Leukemia
Enrollment
75 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo
NCT06926634 Phase 2
Recruiting
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (...
Condition
High Grade Neuroendocrine Neoplasms
Enrollment
32 pts
Location
United States
Sponsor
Washington University School o
NCT05992584 Phase 2
Recruiting
Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC
Condition
Hepatocellular Carcinoma
Enrollment
30 pts
Location
China
Sponsor
Second Affiliated Hospital of
NCT06601933 Phase 2
Recruiting
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Tri...
Condition
Mild Cognitive Impairment (MCI)
Enrollment
240 pts
Location
United States
Sponsor
Columbia University
NCT06385990 Phase 2
Recruiting
Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
Condition
Triple Negative Breast Neoplasms
Enrollment
53 pts
Location
China
Sponsor
Hunan Cancer Hospital
NCT06728410 Phase 2
Recruiting
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced I...
Condition
Intrahepatic Cholangiocarcinoma
Enrollment
38 pts
Location
United States
Sponsor
Mehmet Akce
NCT06959082 Phase 2
Recruiting
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy i...
Condition
Head and Neck Cancer Squamous Cell Carcinoma
Enrollment
30 pts
Location
United States
Sponsor
VSPharmTech Co.,Ltd.
NCT05656924 Phase 2
Recruiting
Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Am...
Condition
Diabete Type 2
Enrollment
38 pts
Location
United States
Sponsor
Spaulding Rehabilitation Hospi
NCT06789679 Phase 2
Recruiting
Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treat...
Condition
Pancreatic Adenocarcinoma
Enrollment
128 pts
Location
China
Sponsor
Cancer Institute and Hospital,
NCT06907342 Phase 2
Recruiting
Testing a Functional Precision Medicine Approach to Select Chemotherapy for Meta...
Condition
Tumor, Colorectal
Enrollment
148 pts
Location
Norway
Sponsor
St. Olavs Hospital
NCT06650852 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, ...
Condition
Chronic Hepatitis B Virus (HBV) Infection
Enrollment
250 pts
Location
China
Sponsor
Brii Biosciences Limited
NCT06463743 Phase 2
Recruiting
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple...
Condition
Multiple Sclerosis
Enrollment
30 pts
Location
United States
Sponsor
State University of New York a
NCT05004974 Phase 2
Recruiting
Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Adv...
Condition
Advanced Non Small Cell Lung Cancer
Enrollment
20 pts
Location
China
Sponsor
The Fourth Affiliated Hospital
NCT05031897 Phase 2
Recruiting
Two Step Haplo With Radiation Conditioning
Condition
Acute Lymphoblastic Leukemia
Enrollment
63 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT04637620 Phase 2
Recruiting
NMDA Modulation in Major Depressive Disorder
Condition
Major Depressive Disorder
Enrollment
90 pts
Location
Taiwan
Sponsor
China Medical University Hospi
NCT06764680 Phase 2
Recruiting
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy ...
Condition
Colorectal Cancer Metastatic
Enrollment
57 pts
Location
China
Sponsor
Sun Yat-sen University
NCT06244888 Phase 2
Recruiting
Control Systems Engineering for Weight Loss Maintenance
Condition
Overweight and Obesity
Enrollment
180 pts
Location
United States
Sponsor
The Miriam Hospital
NCT05588388 Phase 2
Recruiting
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in ...
Condition
Extensive-stage Small-cell Lung Cancer
Enrollment
39 pts
Location
United States
Sponsor
Kamya Sankar
NCT06425341 Phase 2
Recruiting
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficac...
Condition
Chronic Hepatitis B
Enrollment
369 pts
Location
China
Sponsor
Fujian Shengdi Pharmaceutical